Lockheed Martin Corporation (BIT:1LMT)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	88,198	111,257	101,732	119,298	86,187	81,192
Market Cap Growth	-12.33%	9.36%	-14.72%	38.42%	6.15%	-17.04%
Enterprise Value	105,564	126,876	114,251	127,766	94,054	88,650
Last Close Price	372.60	462.99	394.39	427.63	287.74	257.23
PE Ratio	24.58	21.59	16.25	22.24	15.52	14.54
PS Ratio	1.44	1.62	1.66	1.93	1.46	1.52
PB Ratio	19.37	18.19	16.45	13.76	8.94	16.45
P/FCF Ratio	-	21.79	18.05	20.79	12.73	15.48
P/OCF Ratio	-	16.52	14.20	16.34	10.63	12.14
EV/Sales Ratio	1.72	1.85	1.87	2.07	1.60	1.66
EV/EBITDA Ratio	16.51	15.65	12.35	15.84	11.87	10.84
EV/EBIT Ratio	20.85	18.29	13.94	18.28	13.68	12.22
EV/FCF Ratio	37.15	24.85	20.27	22.27	13.89	16.90
Debt / Equity Ratio	4.06	3.38	2.55	1.68	1.07	2.02
Debt / EBITDA Ratio	2.90	2.47	1.71	1.80	1.30	1.22
Debt / FCF Ratio	6.50	4.05	2.80	2.54	1.52	1.90
Asset Turnover	1.26	1.32	1.28	1.27	1.32	1.33
Inventory Turnover	19.40	19.38	18.97	18.98	17.76	15.83
Quick Ratio	0.80	0.92	0.99	1.09	1.15	1.05
Current Ratio	0.99	1.13	1.21	1.32	1.42	1.39
Return on Equity (ROE)	73.06%	81.05%	85.96%	56.68%	74.31%	149.59%
Return on Assets (ROA)	6.47%	8.31%	10.75%	9.00%	9.62%	11.29%
Return on Capital (ROIC)	14.06%	17.25%	23.06%	19.68%	23.94%	32.61%
Return on Capital Employed (ROCE)	17.10%	19.80%	25.50%	20.20%	21.20%	24.10%
Earnings Yield	4.07%	4.63%	6.15%	4.50%	6.44%	6.88%
FCF Yield	3.22%	4.59%	5.54%	4.81%	7.85%	6.46%
Dividend Yield	2.48%	2.66%	2.79%	2.49%	3.24%	3.12%
Payout Ratio	73.60%	57.33%	44.16%	52.62%	46.56%	40.45%
Buyback Yield / Dilution	3.23%	4.78%	5.06%	4.61%	1.35%	0.92%
Total Shareholder Return	5.71%	7.44%	7.85%	7.11%	4.59%	4.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.